SLRX vs VZ · $4.9M cap vs P/E 11, rev $34.25B
Salarius Pharmaceuticals Inc (SLRX) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Latest reported VZ revenue for 2026-06-30 was $34.25B. Net income was $3.83B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
SLRX currently screens at market cap $4.9M. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the SLRX and VZ stock pages for the full models.
Not investment advice.